MINDCURE Announces Partnership with Speak Ai to Enhance iSTRYM, the Company s Psychedelic Digital Therapeutics Technology Platform
News provided by
Share this article
Share this article
Utilizing Speak Ai s technology, iSTRYM will provide Ai-driven intelligence to help therapists identify the most efficient and efficacious outcomes for patients of psychedelic assisted psychotherapy
VANCOUVER, BC, April 13, 2021 /PRNewswire/ - Mind Cure Health Inc. (CSE: MCUR) (OTCQB: MCURF) (FRA: 6MH) ( MINDCURE or the Company ) a leader in advanced proprietary technology for psychedelic therapy, is pleased to announce that it has entered into a partnership with Speak Ai Inc. ( Speak Ai ). The Canadian-based technology company helps individuals and organizations analyze media, language, and metadata to automatically generate valuable insights through machine learning. MINDCURE will be integrating the platform s capabilities into iSTRYM, and will also work with Speak Ai to develop prop